Standard BioTools Inc.
NASDAQ: LAB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Michael Egholm
- Employees
- 388
- Headquarters
- Boston, United States
- IPO year
- 2011
- Market cap
- $293.9M
- Website
- https://www.standardbio.com
Loading LAB…
Loading profile data…Frequently asked questions about LAB
What does Standard BioTools Inc. (LAB) do?
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its...
Where does LAB trade?
Standard BioTools Inc. (LAB) trades on the NASDAQ.
What sector is LAB in?
Standard BioTools Inc. (LAB) operates in the Healthcare sector, specifically in the Medical - Equipment & Services industry.
Who is the CEO of Standard BioTools Inc.?
Michael Egholm is the chief executive officer of Standard BioTools Inc. (LAB).
Where is Standard BioTools Inc. headquartered?
Standard BioTools Inc. is headquartered in United States.
Does LAB pay a dividend?
Standard BioTools Inc. (LAB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LAB go public?
Standard BioTools Inc. (LAB) completed its initial public offering in 2011.